Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Finder | HCA UK
Scientific Lecture | Kevin Harrington | FRONTAL
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
Prof. Kevin Harrington | HSTalks
Loop | Kevin Joseph Harrington
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
ESMO Immuno-Oncology Virtual Congress 2020 | #ESMOImmuno20 Virtual Congress: Prof. Kevin Harrington, Scientific Co-Chair, tells you why this event is so unique. Remember that ESMO Members register... | By ESMO - European
The ICR (@ICR_London) / Twitter
Professor Kevin Harrington - YouTube
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
ESMO Immuno-Oncology Congress 2022: Who should take part in this event? - YouTube
Kevin Harrington, PhD on KEYNOTE-048 #ASCO2020 #ASCO
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
